The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling

被引:15
|
作者
Likhite, Neah [1 ]
Jackson, Christopher A. [1 ]
Liang, Mao-Shih [2 ]
Krzyzanowski, Michelle C. [1 ]
Lei, Pedro [2 ]
Wood, Jordan F. [1 ]
Birkaya, Barbara [1 ]
Michaels, Kerry L. [1 ]
Andreadis, Stelios T. [2 ]
Clark, Stewart D. [3 ,4 ,5 ]
Yu, Michael C. [1 ]
Ferkey, Denise M. [1 ]
机构
[1] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA
[4] SUNY Buffalo, Dept Psychol, Buffalo, NY 14214 USA
[5] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14214 USA
基金
美国国家科学基金会;
关键词
CAENORHABDITIS-ELEGANS; C-ELEGANS; DORSAL STRIATUM; METHYLATION; LOCALIZATION; MECHANISMS; BEHAVIORS; BINDING; SENSITIVITY; ADDICTION;
D O I
10.1126/scisignal.aad0872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methylation regulates diverse functions of eukaryotic cells, including gene expression, the DNA damage response, and circadian rhythms. We showed that arginine residues within the third intracellular loop of the human D2 dopamine receptor, which are conserved in the DOP-3 receptor in the nematode Caenorhabditis elegans, were methylated by protein arginine methyltransferase 5 (PRMT5). By mutating these arginine residues, we further showed that their methylation enhanced the D2 receptor-mediated inhibition of cyclic adenosine monophosphate (cAMP) signaling in cultured human embryonic kidney (HEK) 293T cells. Analysis of prmt-5-deficient worms indicated that methylation promoted the dopamine-mediated modulation of chemosensory and locomotory behaviors in C. elegans through the DOP-3 receptor. In addition to delineating a previously uncharacterized means of regulating GPCR (heterotrimeric guanine nucleotide-binding protein-coupled receptor) signaling, these findings may lead to the development of a new class of pharmacological therapies that modulate GPCR signaling by changing the methylation status of these key proteins.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Type II protein arginine methyltransferase 5 (PRMT5) is required for circadian period determination in Arabidopsis thaliana
    Hong, Sunghyun
    Song, Hae-Ryong
    Lutz, Kerry
    Kerstetter, Randall A.
    Michael, Todd P.
    McClung, C. Robertson
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (49) : 21211 - 21216
  • [42] Structural insights into protein arginine symmetric dimethylation by PRMT5
    Sun, Litao
    Wang, Mingzhu
    Lv, Zongyang
    Yang, Na
    Liu, Yingfang
    Bao, Shilai
    Gong, Weimin
    Xu, Rui-Ming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (51) : 20538 - 20543
  • [43] The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling
    Dacwag, Caroline S.
    Ohkawa, Yasuyuki
    Pal, Sharmistha
    Sif, Said
    Imbalzano, Anthony N.
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) : 384 - 394
  • [44] Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
    Vlummens, Philip
    Verhulst, Stefaan
    De Veirman, Kim
    Maes, Anke
    Menu, Eline
    Moreaux, Jerome
    De Boussac, Hugues
    Robert, Nicolas
    De Bruyne, Elke
    Hose, Dirk
    Offner, Fritz
    Vanderkerken, Karin
    Maes, Ken
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [45] PRMT5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family
    Rho, J
    Choi, S
    Seong, YR
    Cho, WK
    Kim, SH
    Im, DS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 11393 - 11401
  • [46] MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
    Kryukov, Gregory V.
    Wilson, Frederick H.
    Ruth, Jason R.
    Paulk, Joshiawa
    Tsherniak, Aviad
    Marlow, Sara E.
    Vazquez, Francisca
    Weir, Barbara A.
    Fitzgerald, Mark E.
    Tanaka, Minoru
    Bielski, Craig M.
    Scott, Justin M.
    Dennis, Courtney
    Cowley, Glenn S.
    Boehm, Jesse S.
    Root, David E.
    Golub, Todd R.
    Clish, Clary B.
    Bradner, James E.
    Hahn, William C.
    Garraway, Levi A.
    SCIENCE, 2016, 351 (6278) : 1214 - 1218
  • [47] Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
    Zheng, Jiahong
    Li, Bang
    Wu, Yingqi
    Wu, Xiaoshuang
    Wang, Yuanxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8407 - 8427
  • [48] Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma
    Sun, Xiuying
    Zhou, Jinhui
    Zhang, Zhicun
    BIOENGINEERED, 2022, 13 (04) : 8712 - 8723
  • [49] The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription
    Fan, Zhiwen
    Kong, Xiaocen
    Xia, Jun
    Wu, Xiaoyan
    Li, He
    Xu, Huihui
    Fang, Mingming
    Xu, Yong
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (05): : 687 - 696
  • [50] Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A
    Sakai, Nobuya
    Saito, Yumiko
    Fujiwara, Yoko
    Shiraki, Takashi
    Imanishi, Yorihisa
    Koshimizu, Taka-aki
    Shibata, Katsushi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 778 - 784